Adaptive Biotechnologies Corporation Stock
Equities
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.08 USD | -3.10% |
|
+5.07% | -13.30% |
| Capitalization | 2.17B 1.84B 1.7B 1.6B 2.97B 202B 3.02B 19.92B 7.81B 97.05B 8.13B 7.96B 345B | P/E ratio 2026 * |
-29x | P/E ratio 2027 * | -53.4x |
|---|---|---|---|---|---|
| Enterprise value | 2.05B 1.74B 1.61B 1.52B 2.82B 191B 2.86B 18.87B 7.39B 91.9B 7.7B 7.54B 327B | EV / Sales 2026 * |
7.27x | EV / Sales 2027 * | 5.82x |
| Free-Float |
97.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | -3.10% | ||
| 1 week | +5.07% | ||
| Current month | +1.44% | ||
| 1 month | +5.71% | ||
| 3 months | -19.63% | ||
| 6 months | -18.47% | ||
| Current year | -13.30% |
| 1 week | 12.82 |  | 14.86 |
| 1 month | 12.02 | | 15.61 |
| Current year | 12 | | 19.8 |
| 1 year | 6.77 | | 20.76 |
| 3 years | 2.28 | | 20.76 |
| 5 years | 2.28 | | 44.97 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harlan Robins
CTO | Chief Tech/Sci/R&D Officer | 53 | 08/09/2009 |
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.54% | 2.68% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.10% | +5.07% | +87.98% | +78.00% | 2.17B | |
| -2.97% | +5.36% | +4.76% | +50.62% | 2.62B | |
| +0.32% | +1.38% | -16.28% | -46.42% | 2.27B | |
| -0.52% | -5.24% | +23.78% | -32.62% | 1.57B | |
| -2.68% | +17.95% | +296.07% | - | 1.05B | |
| +27.60% | +34.33% | +23.05% | +152.48% | 1.15B | |
| +2.26% | +6.64% | +2.68% | -7.43% | 776M | |
| +0.59% | -0.29% | -7.32% | -10.38% | 703M | |
| -2.57% | +9.65% | +98.26% | -75.83% | 499M | |
| +0.79% | +15.19% | - | - | 471M | |
| Average | +1.97% | +8.45% | +57.00% | +13.55% | 1.33B | |
| Weighted average by Cap. | +1.17% | +6.94% | +45.82% | +22.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 282M 240M 221M 209M 387M 26.28B 394M 2.6B 1.02B 12.64B 1.06B 1.04B 44.95B | 347M 294M 272M 256M 475M 32.25B 483M 3.18B 1.25B 15.51B 1.3B 1.27B 55.16B |
| Net income | -74.92M -63.62M -58.74M -55.38M -103M -6.97B -105M -688M -270M -3.35B -281M -275M -11.92B | -42.17M -35.81M -33.06M -31.17M -57.82M -3.92B -58.82M -387M -152M -1.89B -158M -155M -6.71B |
| Net Debt | -115M -97.72M -90.23M -85.06M -158M -10.71B -161M -1.06B -414M -5.15B -432M -423M -18.32B | -153M -130M -120M -113M -209M -14.22B -213M -1.4B -550M -6.84B -573M -561M -24.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 14.08 $ | -3.10% | 1,303,071 |
| 15/04/26 | 14.53 $ | 0.00% | 949,024 |
| 14/04/26 | 14.53 $ | +2.83% | 1,367,456 |
| 13/04/26 | 14.13 $ | +10.48% | 3,126,170 |
| 10/04/26 | 12.79 $ | -4.55% | 3,310,061 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition